ISG15 and cancer: Besides promoting cancer progression, ISG15 and ISGylation also contribute to therapy resistance, serving as key mediators for resistance to chemotherapy and radiation therapy, particularly through their roles in the IFN-related DNA damage resistance signature (IRDS) [123,158].